Abbott Reports Strong Growth in First Quarter

The first quarter is in the books and Abbott showed strong results, positioning the company for long-term sustainable and organic growth.


For the quarter, we beat Street estimates on the top and bottom lines, and we expect to continue to deliver top-tier sales and double-digit EPS growth throughout 2018. With today’s results, Abbott has met or beaten Street adjusted EPS estimates every quarter for more than 10 years.

The strong growth we delivered this quarter is a direct result of the strategic steps we’ve taken to position the company in the most attractive areas of healthcare and the productivity of our technologies. In the first quarter:

We continued our leadership in Cardiovascular Devices through our rapidly growing portfolio.

We continued to revolutionize how people manage their diabetes.

We continue to personalize and harmonize the lab with our diagnostics technology.

Read more about the first quarter growth at Abbot.com.

Latest News

5 Biggest News Stories of the Week: May 26

As the saying goes, the news never stops — but there’s a lot of it out there, and all of it doesn’t always pertain to our readers. In this weekly news roundup, we’ll cover the top news stories that matter most to our diversity focused audience. 1. More Than 200…

Tips from KeyBank on Improving Mental Health in the Workplace

With May being Mental Health Awareness Month, many companies are looking into how to support employees’ mental health and wellbeing in and out of the workplace.  For KeyBank (ranked No. 18 on the 2022 DiversityInc Top 50 Companies for Diversity list), the company listens to its employees and attempts to understand…